HERA TESTING LABORATORIES, INC.
Genetically-modified laboratory rats engineered using TALEN gene editing and spermatogonial stem cell technology for preclinical drug studies.
- Sector
- Biotech
- Headquarters
- LEXINGTON, KY
- Founded
- 2014
- Latest Form D
- $1.1M, Aug 2020
- Total capital
- $4.2M
- Federal grants
- $775K
- 1 award · 2016
- At sector median 1 award
- Private capital raised
- $3.4M
- 4 Form D · last Aug 2020
- 75 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 7 pending · first 2021
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$1.1M
- Private capital raisedForm D · SEC · 3rd filing$525K
- Private capital raisedForm D · SEC · 2nd filing$700K
- Federal grantHealth and Human S · Phase II · Novel method to create knockout rats using endonucleases and spermatogonial stem$775K
- Private capital raisedForm D · SEC · 1st filing$1.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing in Biotech · 4373 companies
Line = median- Federal contractsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Eric M OstertagResearcherExecutive OfficerLinked by 3 patents
- Christopher H. YoungExecutive Officer, DirectorNamed in SEC Form D filings
- Jack M CrawfordExecutive OfficerNamed in SEC Form D filings
- Michael J. SchlosserExecutive Officer, DirectorNamed in SEC Form D filings
- Thomas M IsettExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 10- GrantedGenetically Modified Rat Models For Severe Combined Immunodeficiency (scid)USPTOUS 12,274,247
- PendingGenetically Modified Rat Models For Severe Combined Immunodeficiency (scid)USPTOApplication 18508906
- GrantedGenetically Modified Rat Models For Severe Combined Immunodeficiency (scid)USPTOUS 11,849,709
Show all 10 patent records
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)Apr 15, 2025 · US 12,274,247Granted
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)May 16, 2024 · Application 18508906Pending
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)Dec 26, 2023 · US 11,849,709Granted
- Genetically Modified Rat Models For Severe Combined Immunodeficiency (scid)Aug 17, 2021 · US 11,089,765Granted
- Novel Immunodeficient Rat For Modeling Human CancerApr 1, 2021 · Application 16499439Pending
- Genetically Modified Non-human Mammals Having Modified Liver Cells And/or Tissue And Methods Of Making SameApr 27, 2017 · Application 15299685Pending
- Novel Immunodeficient Rat For Modeling Human CancerApplication PCTUS2018025368Pending
- Novel Immunodeficient Rat For Modeling Human CancerApplication 62479857Pending
- Genetically Modified Non-human Mammals Having Modified Liver Cells And/or Tissue And Methods Of Making SameApplication PCTUS2016058043Pending
- Cellular And/or Tissue Humanized Rodents And Methods Of Making SameApplication 62245049Pending
Related companies, and why
- Everest Biolabs, Inc.Similar federal contract value in Biotech · null in contracts
- SIGNUM BIOSCIENCESSimilar federal contract value in Biotech · null in contracts
- OMVAX, INC.Similar federal contract value in Biotech · null in contracts
- Lassogen, Inc.Similar federal contract value in Biotech · null in contracts
- ONC.AI, INC.Similar federal contract value in Biotech · null in contracts
- PROMAKHOS THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .